What is NDC 62135-501?

62135-501 is the product NDC for Ultramicrosize Griseofulvin, Griseofulvin 165 mg/1 tablet, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ultramicrosize Griseofulvin?

11 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ultramicrosize Griseofulvin NDC 62135-501

NDC codes

FDA NDC Directory

Product NDC (as listed)62135-501Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62135-0501Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
62135-501-30	6213505013062135050130	30 TABLET in 1 BOTTLE (62135-501-30)Marketed from Jan 30, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ultramicrosize Griseofulvin
Generic name (nonproprietary): ultramicrosize griseofulvin
Active ingredients: Griseofulvin — 165 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Chartwell RX, LLCNDC labeler code 62135
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 061996
Marketing start: Apr 6, 1982
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Mitosis (Physiologic effect)Microtubule Inhibition (Physiologic effect)
Identifiers: Product ID 62135-501_2e9858c1-8c99-8a0d-e063-6294a90a59a5SPL ID 2e9858c1-8c99-8a0d-e063-6294a90a59a5SPL set ID 640c489e-f491-4805-a390-ef4be43e261bRxCUI 245248UNII 32HRV3E3D5UPC 0362135501303
Pharmacologic class: Tubulin Inhibiting Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462135050130 followed by a unit qualifier and the quantity

Package 62135-0501-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 20, 2025.

Indications (excerpt from the label)

INDICATIONS Ultramicrosize griseofulvin tablets are indicated for the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, tinea capitis, tinea unguium (onychomycosis) when caused by one or more of the following genera of fungi: Trichophyton rubrum, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitale, Trichophyton verrucosum, Trichophyton megninii, Trichophyton gallinae, Trichophyton crateriforme, Trichophyton sulphureum, Trichophyton schoenieinii, Microsporum audouini, Microsporum canis, Microsporum gypseum, and Epidermophyton floccosum. Note: Prior to therapy, the type of fungi responsibl…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62135-501

What is NDC 62135-501?: 62135-501 is the product NDC for Ultramicrosize Griseofulvin, Griseofulvin 165 mg/1 tablet, listed with the FDA by Chartwell RX, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ultramicrosize Griseofulvin.
What is the active ingredient?: Griseofulvin.
Who is the labeler?: Chartwell RX, LLC, NDC labeler code 62135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ultramicrosize Griseofulvin?: 11 other product NDCs are listed under this name. See all Ultramicrosize Griseofulvin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ultramicrosize Griseofulvin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 125 mg/1	TabletOral	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	23155-863	23155-0863-01
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 250 mg/1	TabletOral	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	23155-864	23155-0864-01
Ultramicrosize Griseofulvin	Griseofulvin 125 mg/1	Tablet, CoatedOral	Sandoz Inc	0781-5827	00781-5827-0100781-5827-05
Ultramicrosize Griseofulvin	Griseofulvin 250 mg/1	Tablet, CoatedOral	Sandoz Inc	0781-5828	00781-5828-0100781-5828-05
Ultramicrosize Griseofulvinultramicrosize griseofulvin tablets	Griseofulvin 125 mg/1	Tablet, CoatedOral	Amneal Pharmaceuticals of New York LLC	0115-1724	00115-1724-0100115-1724-02
Ultramicrosize Griseofulvinultramicrosize griseofulvin tablets	Griseofulvin 250 mg/1	Tablet, CoatedOral	Amneal Pharmaceuticals of New York LLC	0115-1725	00115-1725-0100115-1725-03
Ultramicrosize Griseofulvin	Griseofulvin 125 mg/1	TabletOral	Sigmapharm Laboratories, LLC	42794-013	42794-0013-08
Ultramicrosize Griseofulvin	Griseofulvin 250 mg/1	TabletOral	Sigmapharm Laboratories, LLC	42794-014	42794-0014-08
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 125 mg/1	TabletOral	Chartwell RX, LLC.	62135-494	62135-0494-0162135-0494-30
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 250 mg/1	TabletOral	Chartwell RX, LLC.	62135-495	62135-0495-0162135-0495-30

All 12 Ultramicrosize Griseofulvin NDCs

Other NDCs under ANDA 061996

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 061996
Product	Strength	Form · route	Labeler	Product NDC
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 125 mg/1	TabletOral	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	23155-863
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 250 mg/1	TabletOral	Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc	23155-864
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 125 mg/1	TabletOral	Chartwell RX, LLC.	62135-494
Ultramicrosize Griseofulvingriseofulvin	Griseofulvin 250 mg/1	TabletOral	Chartwell RX, LLC.	62135-495
Ultramicrosize Griseofulvin	Griseofulvin 165 mg/1	TabletOral	Ayurax, LLC.	73308-435